| Advantages | They retain defining features of colorectal cancer (CRC), including genetic mutations and protein expression patterns, making them dependable systems for CRC research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Intestine (Colon) |
| Disease | Colorectal cancer |
| Organoid Characterization | Colorectal cancer (CRC) organoids exhibit strong pathological correlation with tumor tissues, expressing key markers such as CDX2, β-catenin (CTNNB1), and CK20 (KRT20). |
| Applications | By preserving tumor heterogeneity and recapitulating aspects of the tumor microenvironment (TME), they enable detailed investigation of disease progression and therapeutic response. These physiologically relevant platforms are essential for advancing precision medicine and supporting the development of next-generation colorectal cancer therapies. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.